🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Subjects will receive multiple sub-doses over a 4-hour period to deliver a ...
Status
Completed
Location
AltaSciences LA
Start Date
2022-01-24
Trial ID
NCT05213728
Treatments Being Tested
VXA-NVV-103 is a phase 1B Randomized, Double-Blind, Placebo-Controlled, Mul...
Status
Completed
Location
Rapid Medical Research
Start Date
2019-03-20
Trial ID
NCT03897309
Treatments Being Tested
This study is designed to evaluate the safety and immunogenicity of two mon...
Status
Completed
Location
Ark Clinical Research
Start Date
2023-01-26
Trial ID
NCT05626803
A Phase 1b, randomized, double-blind, dose-ranging trial to determine the s...
Status
Completed
Location
Celerion, Inc.
Start Date
2017-04-07
Trial ID
NCT03125473
Treatments Being Tested
The primary objective of this study is to determine the safety and immunoge...
Status
Completed
Location
Johnson County Clin Trials - JCCT
Start Date
2025-03-03
Trial ID
NCT06944717
Treatments Being Tested
A Phase 1b, multicenter, randomized, double-blind, placebo-controlled study...
Status
Completed
Location
WCCT
Start Date
2021-04-26
Trial ID
NCT04854746
Treatments Being Tested
To evaluate the immunogenicity of VXA-G1.1-NN with repeat-dose administrati...
Status
Completed
Location
WCCT Global, Inc.
Start Date
2021-04-30
Trial ID
NCT04875676
Treatments Being Tested
This is a Phase 2b randomized, double-blind, placebo-controlled vaccination...
Status
Completed
Location
AltaSciences LA
Start Date
2021-12-27
Trial ID
NCT05212168
Treatments Being Tested
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Trial...
Status
Completed
Location
Celerion, Inc.
Start Date
2016-07-29
Trial ID
NCT02868073
The primary objective of this study is to evaluate the safety and tolerabil...
Status
Completed
Location
WITS RHI Research Centre
Start Date
2023-10-27
Trial ID
NCT07254728
Treatments Being Tested